NetScientific (NSCI)

Sector:

Financials

 108.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 180.00
  • 52 Week Low: 43.00
  • Currency: UK Pounds
  • Shares Issued: 20.98m
  • Volume: 20,345
  • Market Cap: £22.76m
  • RiskGrade: 410
  • Beta: 1.43

NetScientific's ProAxsis gets grant for Covid-19 project

By Josh White

Date: Thursday 10 Dec 2020

LONDON (ShareCast) - (Sharecast News) - Technology commercialisation company NetScientific announced on Thursday that its portfolio company ProAxsis has been awarded a high impact Innovate UK grant, as part of the recent 'UKRI Ideas to Address Covid-19' competition.
The AIM-traded firm said ProAxsis would immediately initiate the £0.39m project, which would be co-funded by Innovate UK, to develop novel protease biomarkers to identify high-risk patients.

It said the development activity supported the goal for ProAxsis to fully establish itself as "£the leading commercial protease diagnostic provider of choice" globally.

The grant support would enable ProAxsis to expand its services available to the growing global client list of pharmaceutical companies and academic laboratories, enhance the 'NEATstik' point-of-care test, and realise the opportunities in the Covid-19 response.

"This is the fifth independently-assessed grant awarded to the company in 2020, enabling partial funding support of projects with a total overall value of over £1m," said John Clarkson, chairman of both NetScientific and ProAxsis.

"Despite the challenging environment and lockdown interruption, ProAxsis has made strong progress this year and this latest announcement illustrates the increased commercial potential for its respiratory diagnostics offering in a post-Covid-19 world."

At 1103 GMT, shares in NetScientific were up 4.21% at 49.5p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

NetScientific Market Data

Currency UK Pounds
Share Price 108.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 180.00
52 Week Low 43.00
Volume 20,345
Shares Issued 20.98m
Market Cap £22.76m
Beta 1.43
RiskGrade 410

NetScientific Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.54% below the market average33.54% below the market average33.54% below the market average33.54% below the market average33.54% below the market average
34.88% below the sector average34.88% below the sector average34.88% below the sector average34.88% below the sector average34.88% below the sector average
Price Trend
95.60% above the market average95.60% above the market average95.60% above the market average95.60% above the market average95.60% above the market average
91.30% above the sector average91.30% above the sector average91.30% above the sector average91.30% above the sector average91.30% above the sector average
Income Not Available
Growth
23.79% above the market average23.79% above the market average23.79% above the market average23.79% above the market average23.79% above the market average
26.67% above the sector average26.67% above the sector average26.67% above the sector average26.67% above the sector average26.67% above the sector average

NetScientific Dividends

No dividends found

Trades for 03-Dec-2021

Time Volume / Share Price
15:45 1 @ 107.00p
15:45 5,000 @ 107.05p
15:17 500 @ 107.05p
15:03 9,107 @ 109.80p
14:40 900 @ 107.05p

NetScientific Key Personnel

CEO Ilian Iliev
CFO Stephen Crowe

Top of Page